Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMC-1 for Fibromyalgia
NCT04748705Phase 2Completed
- Sponsor
- Dogwood Therapeutics, Inc.
- Start
- Jun 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of famciclovir + celecoxib in fibromyalgia (FM), sponsored by Dogwood Therapeutics, Inc.. Started Jun 2021; status: completed.
02
Drugs
famciclovir + celecoxib
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT04748705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04748705.